Exchange Traded Concepts, LLC Editas Medicine, Inc. Transaction History

Exchange Traded Concepts, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 12, 2023	BUY	$7.03 - $11.53 $60,774 - $99,676	8,645 Added 9.87%	96,261 $697,000
Q4 2022 Jan 17, 2023	BUY	$8.32 - $13.21 $728,965 - $1.16 Million	87,616 New	87,616 $777,000
Q2 2022 Jul 20, 2022	BUY	$9.99 - $21.35 $68,151 - $145,649	6,822 Added 9.85%	76,098 $900,000
Q1 2022 Apr 26, 2022	BUY	$14.08 - $27.63 $248,878 - $488,387	17,676 Added 34.26%	69,276 $1.32 Million
Q4 2021 Jan 13, 2022	BUY	$26.55 - $40.57 $671,661 - $1.03 Million	25,298 Added 96.18%	51,600 $1.37 Million
Q3 2021 Oct 18, 2021	SELL	$39.27 - $72.94 $2.73 Million - $5.08 Million	-69,599 Reduced 72.57%	26,302 $1.08 Million
Q2 2021 Jul 30, 2021	BUY	$31.29 - $56.64 $781,186 - $1.41 Million	24,966 Added 35.2%	95,901 $5.43 Million
Q1 2021 Apr 20, 2021	BUY	$39.71 - $90.58 $814,888 - $1.86 Million	20,521 Added 40.7%	70,935 $2.98 Million
Q4 2020 Jan 19, 2021	BUY	$27.07 - $84.35 $1.07 Million - $3.32 Million	39,346 Added 355.49%	50,414 $3.54 Million
Q3 2020 Oct 30, 2020	BUY	$28.06 - $37.16 $112,464 - $148,937	4,008 Added 56.77%	11,068 $311,000
Q2 2020 Jul 15, 2020	BUY	$18.5 - $34.34 $68,598 - $127,332	3,708 Added 110.62%	7,060 $209,000
Q1 2020 Apr 14, 2020	BUY	$14.88 - $32.78 $26,962 - $59,397	1,812 Added 117.66%	3,352 $66,000
Q4 2019 Jan 22, 2020	BUY	$19.49 - $32.63 $30,014 - $50,250	1,540 New	1,540 $46,000

248

57M

410K

394K

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $90M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

Stay updated on Exchange Traded Concepts, LLC with notifications on news.